Gene Therapy for Hemophilia B Patients Aged 12-18 Years Old — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Gene Therapy for Hemophilia B Patients Aged 12-18 Years Old — Stella

Recruiting

Back to Hemophilia B trials

Phase 1 — Early testing in a small group of people (usually 20–80) to evaluate safety, determine safe dosage, and identify side effects.

Trial locations(1 site)

China

Institute of haematology and Blood diseases hospital, Tianjin, Tianjin Municipality

Key details

Phase

Early testing

Sponsor

Institute of Hematology & Blood Diseases Hospital, China

Enrollment target

~9 participants

Started

March 2023

Primary completion

June 2035

Age range

12 Years – 18 Years

Sex

Male only

Last updated February 2025

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.

View full record on ClinicalTrials.gov